Class A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
Subclass 3/08: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48)
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 12005265 | Compositions and methods to modulate cell activity | Aug 06, 20 | Jun 11, 24 | The Rockefeller University; Rensselaer Polytechnic Institute; |
| 11969411 | Administration of berberine metabolites | Jun 07, 21 | Apr 30, 24 | AXCESS GLOBAL SCIENCES, LLC |
| 11963974 | Antisense oligonucleotide and composition for prevention or treatment of glycogen storage disease type Ia | Mar 09, 18 | Apr 23, 24 | NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT; Hiroshima University; DAIICHI SANKYO COMPANY, LIMITED; |
| 11938126 | Method of treating diseases of the visual system | Jun 28, 22 | Mar 26, 24 | MyMD Pharmaceuticals, Inc. |
| 11919891 | Bicyclic compounds useful as GPR120 modulators | Dec 14, 20 | Mar 05, 24 | Valo Health, Inc. |
| 11840527 | Non-fused thiophene derivatives and their uses | Feb 08, 19 | Dec 12, 23 | ENYO PHARMA |
| 11821013 | Blood glucose stabilizing methods and compositions | Mar 15, 23 | Nov 21, 23 | Digestiva, Inc. |
| 11813258 | Therapy for mitochondrial fatty acid beta-oxidation and transport disorders | Jun 10, 21 | Nov 14, 23 | University of Pittsburgh—of the Commonwealth System of Higher Education |
| 11813283 | Therapeutic composition and methods | Nov 28, 22 | Nov 14, 23 | Viscera Labs, Inc. |
| 11807659 | TGR5 modulators and methods of use thereof | Apr 14, 22 | Nov 07, 23 | Intercept Pharmaceuticals, Inc. |
| 11767354 | Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors | Feb 05, 21 | Sep 26, 23 | Janssen Pharmaceutica NV |
| 11767316 | Non-fused thiophene derivatives and their uses | Feb 08, 19 | Sep 26, 23 | ENYO PHARMA |
| 11759441 | Biguanide compositions and methods of treating metabolic disorders | Jul 14, 21 | Sep 19, 23 | Anji Pharmaceuticals Inc. |
| 11759437 | Preventive and therapeutic approach for aberrant cell differentiation and ISR-associated diseases | Sep 22, 17 | Sep 19, 23 | The University of Hong Kong |
| 11732019 | Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors | Feb 05, 21 | Aug 22, 23 | Janssen Pharmaceutica NV |
| 11713462 | Modulation of GYS1 expression | Dec 23, 21 | Aug 01, 23 | Ionis Pharmaceuticals, Inc.; The Hospital for Sick Children; |
| 11701335 | Methods of normalizing amino acid metabolism | Aug 16, 19 | Jul 18, 23 | APR Applied Pharma Research s.a. |
| 11667688 | Glucagon derivative and a composition comprising a long acting conjugate of the same | Jan 14, 22 | Jun 06, 23 | Hanmi Pharm. Co., Ltd |
| 11666634 | Methods and compositions for management of gastrointestinal disorders | Apr 24, 20 | Jun 06, 23 | The Board of Regents of The University of Texas System |
| 11628206 | Method for inhibiting STAT3 activity comprising administering Ssu72 | Jan 21, 21 | Apr 18, 23 | CUROGEN TECHNOLOGY CO., LTD. |
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0158,382 | Agonists Of Free Fatty Acid Receptor 1 And Their Use In Diseases Associated With Said Receptor | Oct 20, 20 | May 16, 24 | Not available |
| 2024/0139,262 | COMPLEX PROBIOTIC COMPOSITION AND METHOD FOR IMPROVING EXERCISE PERFORMANCE OF SUBJECT WITH LOW INTRINSIC AEROBIC EXERCISE CAPACITY | Oct 13, 23 | May 02, 24 | Not available |
| 2024/0139,129 | NOVEL METHOD AND AGENT FOR TREATING, DIAGNOSING AND DETECTING DIABETES AND COMPLICATIONS | Feb 25, 22 | May 02, 24 | Not available |
| 2024/0141,355 | MODULATION OF GYS1 EXPRESSION | Jun 08, 23 | May 02, 24 | Not available |
| 2024/0124,864 | BLOOD GLUCOSE STABILIZING METHODS AND COMPOSITIONS | Dec 12, 23 | Apr 18, 24 | Not available |
| 2024/0115,587 | COMBINATION THERAPIES | Nov 06, 23 | Apr 11, 24 | Not available |
| 2024/0116,998 | GLUCAGON-LIKE PEPTIDE-1 RECEPTOR ANTAGONISTS | Feb 15, 22 | Apr 11, 24 | Not available |
| 2024/0117,060 | ANTI-GLP1R ANTAGONIST ANTIBODIES AND METHODS OF USE THEREOF | Dec 18, 23 | Apr 11, 24 | Not available |
| 2024/0117,333 | BLOOD GLUCOSE STABILIZING METHODS AND COMPOSITIONS | Oct 10, 23 | Apr 11, 24 | Not available |
| 2024/0100,131 | NOVEL USE OF MPK38/MELK AS THERAPEUTIC AGENT FOR OBESITY OR METABOLIC DISEASES SPECIFIC TO MIDDLE-AGED MEN | Jul 03, 23 | Mar 28, 24 | Not available |
| 2024/0074,996 | C5 KETONE COMPOSITIONS AND RELATED METHODS FOR TREATING METABOLIC DYSFUNCTION | Jul 21, 23 | Mar 07, 24 | Keto Innovations, LLC |
| 2024/0075,025 | Therapy for Mitochondrial Fatty Acid Beta-Oxidation and Transport Disorders | Oct 03, 23 | Mar 07, 24 | Not available |
| 2024/0024,287 | APPLICATION OF ANLE138B IN DRUG FOR IMPROVING DIET-INDUCED INSULIN RESISTANCE | Oct 28, 22 | Jan 25, 24 | The First Affiliated Hospital of Shantou University Medical College |
| 2024/0018,208 | CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS | Jun 28, 23 | Jan 18, 24 | Not available |
| 2023/0364,170 | COMPOSITION FOR PREVENTING OR TREATING OBESITY OR DIABETES, COMPRISING ACANTHOPANAX SENTICOSUS EXTRACT AND GARCINIA CAMBOGIA EXTRACT OR COMPOUND ISOLATED THEREFROM | Aug 18, 21 | Nov 16, 23 | Korea Research Institute of Bioscience and Biotechnology |
| 2023/0365,644 | ANTIBODY-COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS | Jan 12, 23 | Nov 16, 23 | Not available |
| 2023/0227,788 | ISOLATION OF BONA FIDE PANCREATIC PROGENITOR CELLS | Feb 27, 23 | Jul 20, 23 | Not available |
| 2023/0142,508 | COMPOUNDS AND METHODS FOR REGULATING INSULIN SECRETION | Nov 21, 22 | May 11, 23 | THE BROAD INSTITUTE, INC.; The General Hospital Corporation; Instituto Carlos Slim de la Salud, A.C.; |
| 2022/0401,390 | TREATMENTS OF DIABETIC MACULAR EDEMA AND IMPAIRED VISUAL ACUITY | Dec 09, 20 | Dec 22, 22 | Not available |
| 2022/0323,427 | SOMATOSTATIN RECEPTOR TYPE 5 AGONIST FOR THE TREATMENT OF HYPERINSULINISM | Feb 16, 22 | Oct 13, 22 | Not available |
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
